hCG
Human chorionic gonadotropin is a two-subunit glycoprotein hormone used in specific prescription products; it is not a short research peptide.
The short version
- Why people discuss it
- Discussed for testicular-function preservation during TRT and male fertility support; female ovulation-trigger treatment uses different protocols. Community interest does not establish benefit or a suitable treatment.
- What it is
- Human chorionic gonadotropin is a two-subunit glycoprotein hormone used in specific prescription products; it is not a short research peptide.
- Biggest caution
- Prescription hCG use depends on the indication, patient population, product and clinical monitoring. That evidence does not validate weight-loss, generalized hormone-optimization or unverified-product claims.
- Stack context
- Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.
Dose and frequency reference
Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.
Source agreement describes reported practice, not clinical validation.
Subcutaneous injection
Community reference · Not clinical guidance- Amount
- 250–500 IU
- Frequency
- 3 times weekly
- Duration / phase
- Reported example: 8–16 weeks; medical duration varies
The new source corroborates 500 IU three times weekly and supplies an 8–16-week community example. This is not a generic fertility protocol or a reason to interrupt indicated treatment. Reference only; this does not establish safety, effectiveness or individual suitability.
Reference source · reviewed 2026-09-12Compare reported schedules
Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.
- PeptideDosages — saved source reviewed September 27, 2026
500 IU SC 3 times/week, 8–16 weeks; page intro incorrectly says weekly, table says three times weekly.
Evidence & sources · Community source profile
AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.
- AxonRep community research synthesisAxonRep synthesis · Checked 2026-09-12
- DailyMed: Novarel chorionic gonadotropin prescribing informationProduct label · Checked 2026-09-12
- PeptideDosages — saved source reviewed September 27, 2026Community reference · Checked 2026-09-27